Point72 Hong Kong’s Instil Bio TIL Stock Holding History

Point72 Hong Kong’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-23	Closed	-$2K	–	2408
2022 Q2	$2K	Buy	+23	New	+$3.26K	﹤0.01%	1796
2021 Q2	–	Sell	-528	Closed	-$265K	–	2348
2021 Q1	$265K	Buy	+528	New	+$271K	0.01%	990

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Point72 Hong Kong's TIL Position: Q3 2022 in Review

Point72 Hong Kong sold out of Instil Bio (TIL) in Q3 2022, closing a stake of 23 shares — an estimated $2K sold.

Point72 Hong Kong first reported a position in TIL in Q1 2021 and held it in 2 quarters. The position peaked at $265K in Q1 2021. 95 funds tracked by Wall St. Rank hold TIL as of Q3 2022.

Point72 Hong Kong reported no remaining Instil Bio position as of Q3 2022 after selling out during the quarter.
Point72 Hong Kong sold 23 Instil Bio shares in Q3 2022, an estimated $2K.
Point72 Hong Kong first reported a position in Instil Bio in Q1 2021 and held it in 2 quarters.
Point72 Hong Kong's Instil Bio position peaked at $265K in Q1 2021.
95 funds tracked by Wall St. Rank held Instil Bio as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.